HK Stock Market Move | WANGUO GOLD GP(03939) rose nearly 7% in the morning session. The rising price of gold has pushed the company's stock price up more than 30% in the past month.
Wanguo Gold Group (03939) rose nearly 7% in the morning session, with a total increase of over 30% for the month. As of the time of writing, the stock was up 5.54% at HK$10.09, with a trading volume of HK$1.97 billion.
WANGUO GOLD GP (03939) rose nearly 7% in early trading, with a cumulative increase of over 30% so far this month. As of the time of writing, it has risen by 5.54%, reaching 10.09 Hong Kong dollars, with a turnover of 1.97 billion Hong Kong dollars.
On the news front, due to escalating geopolitical risks, physical shortages, and uncertainty in the Fed's policies, international spot gold made a historic breakthrough of $4600 per ounce on Monday. Citigroup has aggressively raised its short-term outlook for precious metals, predicting that the price of gold will soar to $5000 per ounce within the next 3 months in a bullish scenario, and silver will reach $100 per ounce. Wall Street investment banks such as Morgan Stanley and J.P. Morgan also maintain a long-term bullish consensus.
Industrial's previous research report pointed out that WANGUO GOLD GP has superior growth and profit capabilities. The company's main growth comes from Shandong Jinling Mining, with the Solomon Gold Mine processing plant initiating a new construction plan of 10 million tons per year. The Zijin Empowerment Project construction, once in operation, will expand the processing scale from the current 3.5 million tons per year to 13.5 million tons per year, and is expected to be completed and put into production by 2028, with an estimated annual gold production of 15 tons, aiming to become a world-class gold mine.
Related Articles
.png)
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.

HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.
.png)
HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.

RECOMMEND

Institutions Bullish On Hong Kong Stocks As Spring Rally Builds; Domestic And Foreign Capital Increase ETF Allocations
13/01/2026

The Sword Over Hong Kong Stocks: IPO Peaks And Unlocking Waves
13/01/2026

Learning From History: The AI Investment Wave Likely To End This Year, But The Fed May Shield U.S. Stocks
13/01/2026


